UBS Oncology Impact Fund, Other: iTeos Therapeutics ITOS Sell · Filed 25/05/15

Trade details

Type: Insider sale
Amount: $8,317,363.86
Shares · price: 1,031,931 sh · $8.06 a share
Held after: 3,452,797 sh
Stock: iTeos Therapeutics ITOS
Person: UBS Oncology Impact FundOther
Trade date: 25/05/13
Filed: 25/05/15
Days to filing: 2 days

Sold 23.0% of holdings

Share of holding sold: 23.0%

iTeos Therapeutics trades, last 26 weeks

What else happened in iTeos Therapeutics around then

Filed or reported within 30 days of the trade day · 25/04/13~25/06/12

UBS Oncology Impact Fund's recent trades

UBS Oncology Impact FundFormer 10% Owner
Planned sale10b5-1 planWerewolf Therapeutics
Planned sale10b5-1 plan
Werewolf Therapeutics
HOWL
$27.3K
80,142 sh
$27.3K
Filed 07/06
Traded 07/06
UBS Oncology Impact FundFormer 10% Owner
Planned sale10b5-1 planWerewolf Therapeutics
Planned sale10b5-1 plan
Werewolf Therapeutics
HOWL
$28.4K
87,916 sh
$28.4K
Filed 06/29
Traded 06/29
UBS Oncology Impact FundFormer 10% Owner
Planned sale10b5-1 planWerewolf Therapeutics
Planned sale10b5-1 plan
Werewolf Therapeutics
HOWL
$99K
202,029 sh
$99K
Filed 05/28
Traded 05/28
UBS Oncology Impact FundFormer 10% Owner
Planned sale10b5-1 planWerewolf Therapeutics
Planned sale10b5-1 plan
Werewolf Therapeutics
HOWL
$123.8K
240,280 sh
$123.8K
Filed 05/18
Traded 05/18
UBS Oncology Impact FundFormer 10% Owner
Planned sale10b5-1 planWerewolf Therapeutics
Planned sale10b5-1 plan
Werewolf Therapeutics
HOWL
$47.5K
69,904 sh
$47.5K
Filed 05/11
Traded 05/11